¹⁸F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.

Autor: Cordoba, Raul, Sánchez-García, Joaquín, Domingo-Domenech, Eva, López Jiménez, Javier, Martínez Pozo, Antonio, Carpio, Cecilia, Bendaña, Ángeles, González, Ana Julia, González de Villambrosia, Sonia, Gómez Codina, José, Navarro, Belén, Rodríguez, Guillermo, Naves, Andrea, Baeza, Lourdes, Martín García-Sancho, Alejandro

Publikováno v: Expert Review of Hematology; Jan-Mar2024, Vol. 17 Issue 1-3, p95-100, 6p

Peripheral T‐cell lymphoma with a T follicular‐helper phenotype: A different entity? Results of the Spanish Real‐T study.

Autor: Martín García‐Sancho, Alejandro, Rodríguez‐Pinilla, Socorro M., Domingo‐Domenech, Eva, Climent, Fina, Sánchez‐Garcia, Joaquín, López Jiménez, Javier, García‐Cosío Piqueras, Mónica, Castellvi, Josep, González, Ana Julia, González de Villambrosia, Sonia, Gómez Codina, José, Navarro, Belén, Rodríguez, Guillermo, Borrero, Juan José, Fraga, Máximo, Naves, Andrea, Baeza, Lourdes, Córdoba, Raúl

Publikováno v: British Journal of Haematology; Oct2023, Vol. 203 Issue 2, p182-193, 12p

¹⁸ F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.

Autor: Cordoba R; Lymphoma Unit, Department of Haematology, Health Research Institute IIS-FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain., Sánchez-García J; Hematology Department Department, IMIBIC Hospital Universitario Reina Sofía, UCO, Cordoba, Andalucía, Spain., Domingo-Domenech E; Hematology Department, Institut Català D'oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., López Jiménez J; Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Martínez Pozo A; Pathology Department, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Barcelona, Spain., Carpio C; Department of Haematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital (HUVH), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Bendaña Á; Hematology Department, Complexo Hospitalario Universitario de Santiago de Compostela, La Coruña, Spain., González AJ; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., González de Villambrosia S; Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Gómez Codina J; Medical Oncology Department, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Navarro B; Hematology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Rodríguez G; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/Universidad de Sevilla, Seville, Spain., Naves A; Medical Department, Takeda Farmacéutica España S.A, Madrid, Spain., Baeza L; Medical Department, Takeda Farmacéutica España S.A, Madrid, Spain., Martín García-Sancho A; Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.

Publikováno v: Expert review of hematology [Expert Rev Hematol] 2024 Jan-Mar; Vol. 17 (1-3), pp. 95-100. Date of Electronic Publication: 2024 Feb 07.